These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 34099745)

  • 1. Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials.
    Amani B; Khanijahani A; Amani B
    Sci Rep; 2021 Jun; 11(1):11974. PubMed ID: 34099745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
    Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
    Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
    Kumar J; Jain S; Meena J; Yadav A
    J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):19-27. PubMed ID: 32860962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
    Zang Y; Han X; He M; Shi J; Li Y
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):775-782. PubMed ID: 32892293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
    Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
    Chi G; Memar Montazerin S; Lee JJ; Kazmi SHA; Shojaei F; Fitzgerald C; Gibson CM
    J Med Virol; 2021 Dec; 93(12):6737-6749. PubMed ID: 34370328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    Kim MS; An MH; Kim WJ; Hwang TH
    PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
    Lewis K; Chaudhuri D; Alshamsi F; Carayannopoulos L; Dearness K; Chagla Z; Alhazzani W;
    PLoS One; 2021; 16(1):e0244778. PubMed ID: 33406138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
    Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
    Sarma P; Kaur H; Kumar H; Mahendru D; Avti P; Bhattacharyya A; Prajapat M; Shekhar N; Kumar S; Singh R; Singh A; Dhibar DP; Prakash A; Medhi B
    J Med Virol; 2020 Jul; 92(7):776-785. PubMed ID: 32297988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
    Shamshirian A; Hessami A; Heydari K; Navaei RA; Ebrahimzadeh MA; Yip GW; Ghasemian R; Sedaghat M; Baradaran H; Yazdi SM; Aboufazeli E; Jafarpour H; Dadgostar E; Tirandazi B; Sadeghnezhad R; Karimifar K; Eftekhari A; Shamshirian D
    Ann Acad Med Singap; 2020 Oct; 49(10):789-800. PubMed ID: 33283842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
    Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Ahuja B; Biswas PS
    Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.